Our communicating science initiatives include working with scientists to help them find ways to display their work in accessible language, as well as community outreach to give our scientists a chance
Read more
[ultimate_heading main_heading=”Latest” alignment=”left” main_heading_font_family=”font_family:|font_call:” main_heading_style=”font-weight:900;” main_heading_font_size=”desktop:44px;” sub_heading_font_family=”font_family:|font_call:” sub_heading_style=”font-weight:700;” sub_heading_font_size=”desktop:20px;” main_heading_margin=”margin-bottom:30px;”]Recent news and stories from the Mass General Research Institute.[/ultimate_heading]
Are the current clinical guidelines for autism spectrum disorder (ASD) weighted too heavily toward male patients? That’s the conclusion of a team of researchers from the Lurie Center for Autism.
Read more
Read more
Researchers from the Psychiatric & Neurodevelopmental Genetics Unit at Mass General recently published a study in JAMA Psychiatry that set out to gain a deeper understanding of the relationship betwee
Read more
Read more
Chronic health problems for individuals in recovery from substance use disorder, 3D mammography in older women and how oxytocin acts on food receptors in the brain.
Read more
Read more
Some people wake up early like clockwork with a chipper attitude and are eager to start the day. Then there those who have a bit of a slower start, but stay up till the wee hours claiming they’re
Read more
Read more
A recent research study from Massachusetts General Hospital points to an intriguing new way to look at celiac disease—by studying its connection to bacterial changes in the blood.
Read more
Read more
Two Mass General clinicians were recently featured in an article about the causes of night sweats and how to treat them. Here are five things to know.
Read more
Read more
Diagnosis and treatment for mental health disorders can be a time and resource-intensive process for patients and providers alike. Could data from digital fitness trackers help?
Read more
Read more
Researchers from Mass General have found a connection between immune cells and metabolism that could contribute diseases such as obesity, diabetes and more.
Read more
Read more
While the FDA’s approval of the first ketamine-based drug for treatment-resistant depression is encouraging, there are still a lot of details to work out, says Cristina Cusin, MD.
Read more
Read more